NRx Pharmaceuticals (NRXP) Looks to Score Double With ANDA and NDA Filings For NRX-101.
Share this article
Corporate
Score 65
Bullish
NRx Pharmaceuticals (NRXP) Looks to Score Double With ANDA and NDA Filings For NRX-101
Mar 25, 2026 18:14 UTC
NRXP, XLV, IHI
Short term
Related Articles
Score 45
Bullish
Santander’s Botin Sees Efficiency Improving in First Quarter
Mar 27, 07:11
Score 85
Bullish
AI Breakthrough From Google Exposes Divide in Memory Chip Stocks
Mar 27, 05:59
Score 65
Bullish
WeRide CEO: Path to Profitability Clearer This Year
Mar 27, 03:47
Score 75
Bullish
DBS Joins Buzzing India ECM Space With Mandate in $1 Billion IPO
Mar 27, 02:00
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.